To analyze patients with primarily unknown pyogenic liver abscess (PLA) and specify optimal therapeutic management, highlighting its clinical significance.
Key Findings:
21.4% of patients had primarily unknown PLA, indicating a significant clinical challenge.
Mean abscess size was 6.5 cm, with 89.4% larger than 3 cm, suggesting a need for aggressive management.
44.6% of patients had unclear etiology; 30.3% had infectious dissemination, underscoring the diagnostic difficulties.
Elevated C-reactive protein was found in 97% of patients, indicating a common inflammatory response.
Interpretation:
The study highlights the complexity of PLA with unknown causes and the need for tailored treatment strategies based on individual patient profiles.
Limitations:
Retrospective design may introduce bias, particularly in treatment adherence.
Limited generalizability due to single-center study, which may not reflect broader populations.
Conclusion:
Further research is needed to refine treatment protocols for primarily unknown PLA, considering the diverse etiologies and patient outcomes to improve clinical practice.
